Antithrombin antigen
- Description
- Antithrombin (AT) deficiency can be sub-typed into quantitative (type I) or qualitative (type II) deficiencies. Type I involves a reduced concentration of a normally functioning molecule, whilst type II involves dysfunctional molecules but typically normal concentration. Concentration of AT irrespective of function is ascertained with a latex immunoassay which employs latex particles coated with antibodies to AT to capture AT in the test plasma. The AT acts as a bridge between latex particles that leads to a degree of agglutination directly proportional to AT concentration, which is measured turbidimetrically.
- Clinical details
- The complex orchestration of cellular and molecular participants of haemostasis achieves a crucial yet fine balance of procoagulant and anticoagulant mechanisms. Deficiencies of natural anticoagulant regulators of secondary haemostasis, such as antithrombin, protein C and protein S, and gain of function mutations in genes for FII and FV, are heritable disorders that can shift this balance and increase the risk of venous thromboembolic disease. Antithrombin (AT) is a serine protease inhibitor whose main target enzymes are thrombin and FXa, although it also possesses activity against FIXa, FXIa and TF:FVIIa. It is more efficient at inhibiting free thrombin and FXa than when they are contained within activation assemblies on clot surfaces, thus acting as a scavenger of potentially lethal enzymes that would otherwise diffuse away and cause unnecessary fibrin formation elsewhere. This serves to localise clot formation to the site of injury and limit coagulation. Hereditary AT deficiency can manifest as a reduced concentration of normally functioning AT, (type I defect), or a deficiency of function, (type II defect).
- Related condition
- Reference range
73 - 102
- Units
- U/dl
- Testing site
- Synnovis : Blood Sciences : St Thomas' Hospital
- Laboratory
- Diagnostic Haemostasis and Thrombosis
- Sample type and volume required
- External requests: Citrated platelet poor plasma 500µL x 1 aliquot Internal requests: please refer to EPR label
- Special sample instructions
The sample should be analysed or manipulated & stored in the laboratory within 4 hours of venepuncture. Please ensure sample tubes are filled exactly to the fill-line as underfilling creates a dilution error and leads to inaccurate results.
- Turnaround time
- 7 - 12 days
- Contacts
Diagnostic Haemostasis and Thrombosis Department
St Thomas’ Hospital
Phone: 020 7188 2797
St Thomas’ Hospital
North Wing – 4th and 5th Floors
Westminster Bridge Road
London SE1 7EHGuy’s Hospital
Phone: 020 7188 7188 ext. 53860
Guy’s Hospital
Southwark Wing – 4th Floor
Great Maze Pond
London SE1 9RT
Outside core hours, contact Duty Haemostasis Biomedical Scientist